Related Experiment Video
Updated: Jun 22, 2026
07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
Understanding genetics of sepsis: will new technology help?
1The Clinical Research, Investigation, and Systems Modeling of Acute Illness Laboratory, University of Pittsburgh, Pittsburgh, PA 15261, USA. yendes@upmc.edu
Critical Care (London, England)
|June 4, 2009
Summary
Genome-wide association studies can identify genetic factors for severe sepsis. Large, multicenter patient cohorts and careful study design are crucial for success.
Area of Science:
- Genomics
- Human Genetics
- Complex Trait Genetics
Background:
- High-throughput genotyping enables analysis of numerous single-nucleotide polymorphisms across the human genome.
- Severe sepsis genetics is a key area of interest for applying advanced genomic technologies.
Discussion:
- Recruiting large patient cohorts is essential for genome-wide association studies in severe sepsis.
- Methodological considerations in study design and statistical analysis are critical for multicenter genome-wide association studies.
Key Insights:
- Genome-wide scans offer powerful tools for dissecting the genetic architecture of complex diseases like sepsis.
- The successful implementation of these studies hinges on robust cohort assembly and rigorous analytical strategies.
Outlook:
- Future research will focus on leveraging large-scale genomic data to uncover novel genetic variants associated with sepsis.
- Optimizing study designs will enhance the power to detect genetic contributions to severe sepsis and inform clinical interventions.
Related Concept Videos
01:29Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
00:57Antibiotic Selection
Overview
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...